Answers are grounded in this paper and cite their sources.
To develop a video vision transformer (ViViT) model based on thyroid contrast-enhanced ultrasound (CEUS) video, applying it to distinguish malignant thyroid nodules and predict BRAFV600E mutation in papillary thyroid carcinoma (PTC). We retrospectively collected thyroid nodules with CEUS videos and divided them into training, validation, and testing sets in a ratio of 4:3:3. The ViViT-CEUS diagnostic model was developed and validated. Its performance was compared with two-dimensional convolutional neural networks (2D-CNN), three-dimensional convolutional neural networks (3D-CNN) and traditional radiomics models. Radiologists with different levels of clinical experience were served as the comparator group. 428 thyroid nodules were included (69 benign, 359 malignant). All malignant nodules were PTC, comprising 267 BRAFV600E mutated and 92 non-mutated cases. The AUC of ViViT-CEUS for diagnosing malignancy was 0.938, which was significantly higher than that of 2D-CNN (AUC = 0.767), 3D-CNN (AUC = 0.790), and radiologists (AUC range : 0.617–0.815). The AUC of ViViT-CEUS for predicting BRAFV600E was 0.865, outperforming 2D-CNN (AUC = 0.704), 3D-CNN (AUC = 0.597), and traditional radiomics models (AUC = 0.682). The ViViT-CEUS model demonstrated high accuracy in identifying malignant thyroid nodules and improved prediction of PTC BRAFV600E mutations compared to alternative methods, providing a basis for identifying molecular features based on dynamic CEUS videos.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: